285 related articles for article (PubMed ID: 12876796)
1. Bioactive products from Streptomyces.
Bĕhal V
Adv Appl Microbiol; 2000; 47():113-56. PubMed ID: 12876796
[No Abstract] [Full Text] [Related]
2. Genetic manipulation of antibiotic-producing Streptomyces.
Baltz RH
Trends Microbiol; 1998 Feb; 6(2):76-83. PubMed ID: 9507643
[TBL] [Abstract][Full Text] [Related]
3. [Production of new antibiotics. Problems and prospects].
Dudnik IuV
Antibiot Khimioter; 1989 Nov; 34(11):807-10. PubMed ID: 2633693
[No Abstract] [Full Text] [Related]
4. [Herbicide antibiotic bialaphos: the stages and genetic control of its biosynthesis; growth of bialaphos-resistant plants].
Lomovskaia ND; Mkrtumian NM; Sezonov GV
Antibiot Khimioter; 1991 Feb; 36(2):3-6. PubMed ID: 2025115
[No Abstract] [Full Text] [Related]
5. [Development of a new method for preparing biologically active compounds based on the typed strain Streptomyces werraensis].
Rusanova EP; Alekhov TA; Fedorova GB; Katrukha GS
Prikl Biokhim Mikrobiol; 2000; 36(3):312-6. PubMed ID: 10867951
[TBL] [Abstract][Full Text] [Related]
6. Engineering Escherichia coli to produce nonribosomal peptide antibiotics.
Challis GL
Nat Chem Biol; 2006 Aug; 2(8):398-400. PubMed ID: 16850013
[No Abstract] [Full Text] [Related]
7. Biotechnological doxorubicin production: pathway and regulation engineering of strains for enhanced production.
Niraula NP; Kim SH; Sohng JK; Kim ES
Appl Microbiol Biotechnol; 2010 Jul; 87(4):1187-94. PubMed ID: 20508927
[TBL] [Abstract][Full Text] [Related]
8. Engineering antibiotic producers to overcome the limitations of classical strain improvement programs.
Lal R; Khanna R; Kaur H; Khanna M; Dhingra N; Lal S; Gartemann KH; Eichenlaub R; Ghosh PK
Crit Rev Microbiol; 1996; 22(4):201-55. PubMed ID: 8989512
[TBL] [Abstract][Full Text] [Related]
9. Unlocking Streptomyces spp. for use as sustainable industrial production platforms by morphological engineering.
van Wezel GP; Krabben P; Traag BA; Keijser BJ; Kerste R; Vijgenboom E; Heijnen JJ; Kraal B
Appl Environ Microbiol; 2006 Aug; 72(8):5283-8. PubMed ID: 16885277
[TBL] [Abstract][Full Text] [Related]
10. [Design of Streptomyces nogalater LV65 strains with higher synthesis of nogalamicin using regulatory genes].
Klimishin DA; Rabyk MV; Gren' TP; Nimets' OIa; Gonchar MA; Gromyko AN; Fedorenko VA
Prikl Biokhim Mikrobiol; 2011; 47(6):650-4. PubMed ID: 22288193
[TBL] [Abstract][Full Text] [Related]
11. [Protoplasts of lincomycin producer Streptomyces roseolus in genetic manipulations].
Zakharova GM; Podgornova GP; Metlina MA; Danilenko VN
Antibiot Khimioter; 1991 Oct; 36(10):3-5. PubMed ID: 1805691
[TBL] [Abstract][Full Text] [Related]
12. [Some problems in finding and in the microbiological synthesis of physiologically active compounds].
Bezborodov AM
Antibiotiki; 1975 Oct; 20(10):948-56. PubMed ID: 1211893
[No Abstract] [Full Text] [Related]
13. Exploiting the natural metabolic diversity of Streptomyces venezuelae to generate unusual reduced macrolides.
Park JW; Oh HS; Jung WS; Park SR; Han AR; Ban YH; Kim EJ; Kang HY; Yoon YJ
Chem Commun (Camb); 2008 Nov; (44):5782-4. PubMed ID: 19009080
[TBL] [Abstract][Full Text] [Related]
14. Production of novel chemotherapeutic drugs by Streptomycetes.
Rassi H; Ghasemi SF
Lik Sprava; 2008; (7-8):40-7. PubMed ID: 19663015
[TBL] [Abstract][Full Text] [Related]
15. Natural product biosynthesis: a new interface between enzymology and medicine.
Khosla C
J Org Chem; 2000 Dec; 65(24):8127-33. PubMed ID: 11101363
[No Abstract] [Full Text] [Related]
16. Enhancement and selective production of oligomycin through inactivation of avermectin's starter unit in Streptomyces avermitilis.
Wei X; Yunxiang L; Yinghua Z
Biotechnol Lett; 2006 Jun; 28(12):911-6. PubMed ID: 16786277
[TBL] [Abstract][Full Text] [Related]
17. Biosynthetic studies on the azinomycins: the pathway to the naphthoate fragment.
Corre C; Landreau CA; Shipman M; Lowden PA
Chem Commun (Camb); 2004 Nov; (22):2600-1. PubMed ID: 15543299
[TBL] [Abstract][Full Text] [Related]
18. Production of the antitumor drug epirubicin (4'-epidoxorubicin) and its precursor by a genetically engineered strain of Streptomyces peucetius.
Madduri K; Kennedy J; Rivola G; Inventi-Solari A; Filippini S; Zanuso G; Colombo AL; Gewain KM; Occi JL; MacNeil DJ; Hutchinson CR
Nat Biotechnol; 1998 Jan; 16(1):69-74. PubMed ID: 9447597
[TBL] [Abstract][Full Text] [Related]
19. Genetic engineering of aminodeoxyhexose biosynthesis in Streptomyces fradiae.
Butler AR; Bate N; Kiehl DE; Kirst HA; Cundliffe E
Nat Biotechnol; 2002 Jul; 20(7):713-6. PubMed ID: 12089557
[TBL] [Abstract][Full Text] [Related]
20. Chalcomycin biosynthesis gene cluster from Streptomyces bikiniensis: novel features of an unusual ketolide produced through expression of the chm polyketide synthase in Streptomyces fradiae.
Ward SL; Hu Z; Schirmer A; Reid R; Revill WP; Reeves CD; Petrakovsky OV; Dong SD; Katz L
Antimicrob Agents Chemother; 2004 Dec; 48(12):4703-12. PubMed ID: 15561847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
